Search

everythinglearnresearchcommunity

for

Search:↓

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

Using both minoxidil and finasteride together is more effective for male hair loss than using either one alone.

SHBG may be a useful early indicator and treatment target for PCOS.

Antiandrogen therapy for hidradenitis suppurativa lacks strong evidence and needs more research.

Metformin is less effective in men with early-onset hair loss.

An mFG score of 7 or higher indicates hirsutism in Filipino women, often linked to higher free testosterone levels.

Dermatologists can help diagnose endocrine disorders like PCOS and metabolic syndrome by looking at skin symptoms.

Using polymeric micelles to deliver spironolactone topically could improve wound healing in skin affected by glucocorticoids.

Testosterone implants in women require pharmacological dosing to be effective and are generally safe and well-tolerated.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

The document describes a treatment for excessive hair growth in a teenage girl using medication and birth control, but does not report the results.

Most treatments for hair loss in 1997 were not effective for most people, and maintaining hair growth was difficult.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

Hirsutism is a strong sign of high male hormones and metabolic problems in women with PCOS, but acne and hair loss are not.

Oxidative stress is higher in women with PCOS, especially if they're obese, and it may increase their risk of heart disease.

Ginsenoside Rg3 combined with minoxidil was more effective in treating hair loss in mice.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

Married Egyptian women with PCOS have lower sexual desire compared to those without PCOS.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

Hair loss links to high blood pressure, high fat levels, and metabolic issues, suggesting early heart disease screening.

AGA is a genetic, hormonal hair loss treated with finasteride, minoxidil, and supplements, but new compounds are being developed.

AGA increased yearly, type I most common, and family history and seborrheic dermatitis often linked.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

Excessive hair growth can be assessed by history, exam, and blood tests, and treated with medication like dexamethasone, birth control pills, and spironolactone.

Insulin resistance is linked to larger thyroid volume in patients with polycystic ovary syndrome.

Hair loss can be managed with treatments like minoxidil, finasteride, and others, but there are still gaps in effectiveness and off-label usage is increasing.

5-alpha reductase inhibitors, like finasteride and dutasteride, are used for prostate issues, hair loss, and excessive hair growth, may help with COVID-19, but can cause sexual and mental health side effects, and their use in preventing prostate cancer needs more examination.

Hormones affect skin aging, and treatments targeting hormonal balance may improve skin health.

The document concludes that sex hormones are crucial for mammalian reproduction, health, and behavior, and require more research for therapeutic use.